Application Sponsors
Marketing Status
None (Tentative Approval) | 001 |
None (Tentative Approval) | 002 |
Application Products
001 | TABLET, ORALLY DISINTEGRATING;ORAL | 10MG | 0 | ARIPIPRAZOLE | ARIPIPRAZOLE |
002 | TABLET, ORALLY DISINTEGRATING;ORAL | 15MG | 0 | ARIPIPRAZOLE | ARIPIPRAZOLE |
FDA Submissions
UNKNOWN; | ORIG | 1 | TA | 2018-12-26 | STANDARD |
Submissions Property Types
CDER Filings
PHARMTAK INC
cder:Array
(
[0] => Array
(
[ApplNo] => 208438
[companyName] => PHARMTAK INC
[docInserts] => ["",""]
[products] => [{"drugName":"ARIPIPRAZOLE","activeIngredients":"ARIPIPRAZOLE","strength":"10MG","dosageForm":"TABLET, ORALLY DISINTEGRATING;ORAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"},{"drugName":"ARIPIPRAZOLE","activeIngredients":"ARIPIPRAZOLE","strength":"15MG","dosageForm":"TABLET, ORALLY DISINTEGRATING;ORAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"12\/26\/2018","submission":"ORIG-1","actionType":"Tentative Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2018-12-26
)
)